Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs

Journal of Clinical Virology

Volumn 52, Issue 3, 2011, Pages 198-203

  Chen, Yu ^a   Qian, Fuchu ^b   Yuan, Quan ^c   Li, Xuefen ^d   Wu, Wei ^a   Guo, Xichao ^d   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b HUZHOU CENTRAL HOSPITAL   (China)

^c XIAMEN UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antibody to HBsAg (anti HBs); Genome; Hepatitis B surface antigen (HBsAg); Hepatitis B virus; Variation

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; DNA SEQUENCE; FEMALE; GENE SEQUENCE; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; VIRUS GENOME; VIRUS MUTATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; DNA, VIRAL; GENETIC VARIATION; GENOME, VIRAL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MUTAGENESIS, INSERTIONAL; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 80054681731     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.07.011     Document Type: Article

References (30)

1. Tabor E., Gerety R.J., Smallwood L.A., Barker L.F. Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum. J Immunol 1977, 118:369-370.
2. Yamamoto K., Horikita M., Tsuda F., Itoh K., Akahane Y., Yotsumoto S., et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994, 68:2671-2676.
3. Kohno H., Inoue T., Tsuda F., Okamoto H., Akahane Y. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 1996, 77:1825-1831.
4. Wang Y.M., Ng W.C., Lo S.K. Detection of pre-S/S mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B suface antigen. J Gastroenterol 1999, 34:600-606.
5. Mathet V.L., Feld M., Espinola L., Sánchez D.O., Ruiz V., Mandó O., et al. Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating anti-HBs antibodies. J Med Virol 2003, 69:18-26.
6. Lada O., Benhamou Y., Poynard T., Thibault V. Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of a determinant variants. J Virol 2006, 80:2968-2975.
7. Colson P., Borentain P., Motte A., Henry M., Moal V., Botta-Fridlund D., et al. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Virology 2007, 367:30-40.
8. Carman W.F. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997, 4(Suppl 1):11-20.
9. Chen W.N., Oon C.J., Toh I. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common a determinant. Am J Gastroenterol 2000, 95:1098-1099.
10. Cooreman M.P., Leroux-Roels G., Paulij W.P. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001, 8:237-247.
11. Lu M., Lorentz T. De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody. J Infect Dis 2003, 187:1323-1326.
12. Seddigh-Tonekaboni S., Waters J.A., Jeffers S., Gehrke R., Ofenloch B., Horsch A., et al. Effect of variation in the common a determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000, 60:113-121.
13. Zhang J.M., Xu Y., Wang X.Y., Yin Y.K., Wu X.H., Weng X.H., et al. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis 2007, 44:1161-1169.
14. Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical Association Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J (Engl) 2007, 120:2159-2173.
15. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979, 281:646-650.
16. Gunther S., Li B.C., Miska S., Krüger D.H., Meisel H., Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutant in immunosuppressed patients. J Virol 1995, 69:5437-5444.
17. Yuan Q., Ou S.H., Chen C.R., Ge S.X., Pei B., Chen Q.R., et al. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol 2010, 48:357-362.
18. Huang X., Qin Y., Zhang P., Tang G., Shi Q., Xu J., et al. PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis B surface antigen and anti-HBs antibodies. J Med Virol 2010, 82:23-31.
19. Awerkiew S., Däumer M., Reiser M., Wend U.C., Pfister H., Kaiser R., et al. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol 2007, 38:83-86.
20. Westhoff T.H., Jochimsen F., Schmittel A., Stoffler-Meilicke M., Schafer J.H., Zidek W., et al. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 2003, 102:1930.
21. Terrault N.A., Zhou S., McCory R.W., Pruett T.L., Lake J.R., Roberts J.P., et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology 1998, 28:555-561.
22. Shinji T., Koide N., Hanafusa T., Hada H., Oka T., Takayama N., et al. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen. Hepatogastroenterology 1998, 45:500-502.
23. Kajiwara E., Tanaka Y., Ohashi T., Uchimura K., Sadoshima S., Kinjo M., et al. Hepatitis B caused by a hepatitis B surface antigen escape mutant. J Gastroenterol 2008, 43:243-247.
24. Liu S.L., Dong Y., Zhang L., Li M.W., Wo J.E., Lu L.W., et al. Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China. Arch Virol 2009, 154:437-443.
25. Kao J.H., Chen P.J., Lai M.Y., Chen D.S. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003, 124:327-334.
26. Lin C.L., Liao L.Y., Wang C.S., Chen P.J., Lai M.Y., Chen D.S., et al. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int 2005, 25:564-570.
27. Liu C.J., Chen B.F., Chen P.J., Lai M.Y., Huang W.L., Kao J.H., et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis 2006, 193:1258-1265.
28. Kuang S.Y., Jackson P.E., Wang J.B., Lu P.X., Muñoz A., Qian G.S., et al. Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci USA 2004, 101:3575-3580.
29. Yang H.I., Yeh S.H., Chen P.J., Iloeje U.H., Jen C.L., Su J., et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008, 100:1134-1143.
30. Liu S., Zhang H., Gu C., Yin J., He Y., Xie J., et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009, 101:1066-1082.